GPC3 and hepatocellular carcinoma: For instance, multifunctional nanoparticles targeting GPC3, a proteoglycan associated with hepatocellular carcinoma (HCC), have shown enhanced cellular uptake in GPC3-positive HCC cells, highlighting their potential for targeted drug delivery and imaging applications (Liu et al., 2024).